Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
BKE heads into its November earnings with a split picture: short sellers are trimming positions while options traders have turned more bullish than they have been all year.
The short side has been quietly unwinding. Short interest in BKE has pulled back 1.7% over the week to 7.7% of the free float, roughly 3.87 million shares. That monthly picture is less clean: SI is still up 5.7% from a month ago, meaning the recent easing is a modest reversal of a build that ran through September. The lending market is no constraint on bears who want to press the trade. Availability is close to the highest point of the year at 3,242%, meaning shares to borrow vastly outnumber those already borrowed. Cost to borrow is a negligible 0.49%. Nothing in the borrow market is squeezing existing shorts or deterring new ones.
Options positioning tells a different story, and it deserves its own read. Call demand has surged relative to puts, with the put/call ratio falling to 0.33, more than one standard deviation below its 20-day average of 0.41. That is the most bullish options tilt in at least a year; the 52-week high on the PCR was 1.61, so the swing in sentiment has been significant. The direction-of-travel in the ratio has been consistent across the past week, with the PCR drifting lower each session. Options traders are leaning into upside rather than hedging downside, even with the next earnings date sitting on the calendar for November 27.
The Street is a quieter story. UBS is the only active voice on record, with analyst Mauricio Serna trimming his target to $46 in August while holding a Neutral rating. That target sits just above the current price of $43.63, implying modest upside but no conviction to buy. Note that this coverage data is now nearly two months old. The short score at 57.8 is middling and has drifted slightly lower over the past two weeks, consistent with the easing in short interest. The factor picture gives BKE a 70th percentile dividend score but only a 16th percentile short score rank, flagging it as a name that remains in shorts' crosshairs relative to the broader market.
Ownership is notable for its concentration. Daniel Hirschfeld holds 32% of shares outstanding, a level that has not changed in recently reported filings. Dennis Nelson holds another 4.3%. Between them and a passive-heavy institutional register that includes BlackRock at 9.8% and Vanguard at 5%, the free float available for trading is limited, which may amplify the impact of any positioning shifts. Insider activity over the past 90 days has been minimal: one director sold $111,000 worth of stock in June, against a backdrop of larger discretionary sales earlier in the year at prices in the $49 to $55 range. No open-market buying has been recorded.
Retail attention has picked up sharply. The Wikipedia views signal for BKE is running at a z-score of 2.8 against its own prior 90 days, the highest attention reading in the dataset window. This is a measure of awareness, not a financial indicator, but it sits alongside the bullish options skew as a signal that interest in the name is elevated heading into the next few weeks.
The setup to watch: whether the bullish options tilt and the easing in short interest cohere into a broader re-rating, or whether the stock remains rangebound near $43 to $44 as UBS's Neutral anchor and the lingering monthly SI build create offsetting gravity ahead of the late-November print.
See the live data behind this article on ORTEX.
Open BKE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
